Holen Sie sich die Stockscreener-App
17.12
1.15%
-0.20
Handel nachbörslich:
17.12
Schlusskurs vom Vortag:
$17.32
Offen:
$17.32
24-Stunden-Volumen:
317.06K
Relative Volume:
0.65
Marktkapitalisierung:
$459.12M
Einnahmen:
$31.38M
Nettoeinkommen (Verlust:
$-6.69M
KGV:
-65.85
EPS:
-0.26
Netto-Cashflow:
$-1.84M
1W Leistung:
+12.19%
1M Leistung:
+18.15%
6M Leistung:
+1.84%
1J Leistung:
+354.11%
1-Tages-Spanne:
$16.98
$17.50
1-Wochen-Bereich:
$14.67
$17.54
52-Wochen-Spanne:
$3.75
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Vergleichen Sie ETON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
17.12 | 457.24M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Published on: 2025-08-13 17:16:40 - 선데이타임즈
Eton Pharmaceuticals (NASDAQ:ETON) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript - Insider Monkey
With 43% Ownership in Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Institutional Investors Have a Lot Riding on the Business - 富途牛牛
Loss-Making Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Set To Breakeven - simplywall.st
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates - MSN
Eton Pharmaceuticals Experiences Record Revenue Growth and Analysts See Significant Upside Potential - AInvest
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveFree Stock Selection With High Accuracy - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.Free Secure Capital Picks With Upside Potential - Newser
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
What makes Eton Pharmaceuticals Inc. stock price move sharplyFree Capital Growth With Controlled Risk Picks - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
What institutional flow reveals about Eton Pharmaceuticals Inc.Swing Candidate List with Trade Cues - Newser
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth By Investing.com - Investing.com Canada
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth - Investing.com
Eton Pharmaceuticals Soars 17.23% on 108% Sales Growth - AInvest
Analyzing Eton Pharmaceuticals: A Reasonable Growth Opportunity with Affordable Pricing and Potential Upside from Options. - AInvest
Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals Reports Robust Q2 2025 Growth - TipRanks
Real time pattern detection on Eton Pharmaceuticals Inc. stockBuy/Sell Zone Confirmation Technical Analysis - Newser
Why Eton Pharmaceuticals Inc. is moving todayYield Curve Outlook and Long-Term Implication Summary - Newser
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c - TipRanks
Eton Pharmaceuticals earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersLow Risk High Confidence Watchlist Builder - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser
Quant Tools Rank Eton Pharmaceuticals Inc. as High Risk High RewardVerified Signal From Chart Patterns Detected - beatles.ru
How does Eton Pharmaceuticals Inc. compare to its industry peersMarket-leading profit generation - Jammu Links News
How many analysts rate Eton Pharmaceuticals Inc. as a “Buy”Get daily expert analysis for smarter investing - Jammu Links News
What is the risk reward ratio of investing in Eton Pharmaceuticals Inc. stockFree Stock Market Trend Analysis - Jammu Links News
How volatile is Eton Pharmaceuticals Inc. stock compared to the marketBoost your wealth with consistent growth stocks - Jammu Links News
Is Eton Pharmaceuticals Inc. a good long term investmentFree Stock Market Query - Jammu Links News
Is Eton Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with actionable trading signals - Jammu Links News
Why is Eton Pharmaceuticals Inc. stock attracting strong analyst attentionAchieve consistent profits with smart trading - Jammu Links News
What catalysts could drive Eton Pharmaceuticals Inc. stock higher in 2025Track stocks with high upside potential easily - Jammu Links News
What are the technical indicators suggesting about Eton Pharmaceuticals Inc.Get exclusive market analysis for investors - Jammu Links News
What is the dividend policy of Eton Pharmaceuticals Inc. stockUnlock daily trading alerts for profits - Jammu Links News
Eton Pharmaceuticals Inc. Stock Analysis and ForecastBreakout stock performance - Jammu Links News
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Published on: 2025-07-30 01:43:42 - metal.it
Short Term Charts Align With Long Term Uptrend in Eton Pharmaceuticals Inc.Conservative Long Term Growth Plans Under Review - metal.it
RSI and MACD Indicate Shift in Eton Pharmaceuticals Inc. SentimentHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
How to interpret RSI for Eton Pharmaceuticals Inc. stockFree Step-by-Step Trade Signal Implementation - Newser
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - GlobeNewswire
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):